Effect of mild hypercapnia during the recovery period on the emergence time from total intravenous anesthesia: a randomized controlled trial
Korean Journal of Anesthesiology · 2025
DOI: 10.4097/kja.24363 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Korean Journal of Anesthesiology, 2025. Verfasst von Lan Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Hypercapnia, Anesthesia Recovery Period, Anesthesia, Intravenous. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province, Education Department of Zhejiang Province.
Abstract (Originalsprache)
Background
Intraoperative hypercapnia reduces the time to emergence from volatile anesthetics, but few clinical studies have explored the effect of hypercapnia on the emergence time from intravenous (IV) anesthesia. We investigated the effect of inducing mild hypercapnia during the recovery period on the emergence time after total IV anesthesia (TIVA).
Methods
Adult patients undergoing transurethral lithotripsy under TIVA were randomly allocated to normocapnia group (end-tidal carbon dioxide [ETCO2] 35–40 mmHg) or mild hypercapnia group (ETCO2 50-55 mmHg) during the recovery period. The primary outcome was the extubation time. The spontaneous breathing-onset time, voluntary eye-opening time, and hemodynamic data were collected. Changes in the cerebral blood flow velocity in the middle cerebral artery were assessed using transcranial Doppler ultrasound.
Results
In total, 164 patients completed the study. The extubation time was significantly shorter in the mild hypercapnia (13.9 ± 5.9 min, P = 0.024) than in the normocapnia group (16.3 ± 7.6 min). A similar reduction was observed in spontaneous breathing-onset time (P = 0.021) and voluntary eye-opening time (P = 0.008). Multiple linear regression analysis revealed that the adjusted ETCO2 level was a negative predictor of extubation time. Middle cerebral artery blood flow velocity was significantly increased after ETCO2 adjustment for mild hypercapnia, which rapidly returned to baseline, without any adverse reactions, within 20 min after extubation.
Conclusions
Mild hypercapnia during the recovery period significantly reduces the extubation time after TIVA. Increased ETCO2 levels can potentially enhance rapid recovery from IV anesthesia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
- Department of Anesthesiology, Haiyan People's Hospital, Jiaxing, China.
- Department of Anesthesiology, Hangzhou Women's Hospital, Hangzhou, China.
Förderung
- Natural Science Foundation of Zhejiang Province
- Education Department of Zhejiang Province
Zitieren
APA
Liu, L., Chen, X., Chen, Q., Lu, X., Fang, L., Ren, J., Ming, Y., Sun, D., Chen, P., Wu, W., & Yu, L. (2025). Effect of mild hypercapnia during the recovery period on the emergence time from total intravenous anesthesia: a randomized controlled trial. Korean Journal of Anesthesiology. https://doi.org/10.4097/kja.24363
Vancouver
Liu L, Chen X, Chen Q, Lu X, Fang L, Ren J, et al. Effect of mild hypercapnia during the recovery period on the emergence time from total intravenous anesthesia: a randomized controlled trial. Korean Journal of Anesthesiology. 2025. doi:10.4097/kja.24363
BibTeX
@article{Liu2025,
author = {Liu, Lan and Chen, Xiangde and Chen, Qingjuan and Lu, Xiuyi and Fang, Lili and Ren, Jinxuan and Ming, Yue and Sun, Dawei and Chen, Pei and Wu, Weidong and Yu, Lina},
title = {Effect of mild hypercapnia during the recovery period on the emergence time from total intravenous anesthesia: a randomized controlled trial},
journal = {Korean Journal of Anesthesiology},
year = {2025},
doi = {10.4097/kja.24363}
}
EUVIMED